Using T Using T e c hnology to Impr e c hnology to Impr ove ove - - PDF document

using t using t e c hnology to impr e c hnology to impr
SMART_READER_LITE
LIVE PREVIEW

Using T Using T e c hnology to Impr e c hnology to Impr ove ove - - PDF document

6/10/2019 Using T Using T e c hnology to Impr e c hnology to Impr ove ove Me dic ation Adhe r Me dic ation Adhe r e nc e e nc e L L a c e y Bla nke nship, Pha rm.D., BCPS, NCPS a c e y Bla nke nship, Pha rm.D., BCPS, NCPS Chie f Pha


slide-1
SLIDE 1

6/10/2019 1

Using T e c hnology to Impr

  • ve

Me dic ation Adhe r e nc e Using T e c hnology to Impr

  • ve

Me dic ation Adhe r e nc e

L a c e y Bla nke nship, Pha rm.D., BCPS, NCPS Chie f Pha rma c ist, Musc o g e e (Cre e k) Na tio n, Oke ma h I ndia n He a lth Clinic L a c e y Bla nke nship, Pha rm.D., BCPS, NCPS Chie f Pha rma c ist, Musc o g e e (Cre e k) Na tio n, Oke ma h I ndia n He a lth Clinic

F inanc ial Disc losure s F inanc ial Disc losure s

Unde r g uide line s e sta b lishe d b y the Ac c re dita tio n Co unc il fo r Pha rma c y E duc a tio n, disc lo sure must b e ma de re g a rding fina nc ia l re la tio nships with c o mme rc ia l inte re sts within the la st 12 mo nths.

  • I

ha ve no re le va nt fina nc ia l re la tio nships o r a ffilia tio ns with c o mme rc ia l inte re sts to disc lo se . Unde r g uide line s e sta b lishe d b y the Ac c re dita tio n Co unc il fo r Pha rma c y E duc a tio n, disc lo sure must b e ma de re g a rding fina nc ia l re la tio nships with c o mme rc ia l inte re sts within the la st 12 mo nths.

  • I

ha ve no re le va nt fina nc ia l re la tio nships o r a ffilia tio ns with c o mme rc ia l inte re sts to disc lo se .

slide-2
SLIDE 2

6/10/2019 2

L e ar ning Obje c tive s L e ar ning Obje c tive s

At the c o mple tio n o f this a c tivity, pha rma c ists a nd pha rma c y te c hnic ia ns will b e a b le to :

  • De sc rib e the impa c t o f me dic a tio n a dhe re nc e o n

pa tie nt he a lth

  • Disc uss a va ila b le to o ls to impro ve me dic a tio n

a dhe re nc e

  • I

de ntify the pha rma c ist’ s/ te c hnic ia n’ s ro le in me dic a tio n a dhe re nc e At the c o mple tio n o f this a c tivity, pha rma c ists a nd pha rma c y te c hnic ia ns will b e a b le to :

  • De sc rib e the impa c t o f me dic a tio n a dhe re nc e o n

pa tie nt he a lth

  • Disc uss a va ila b le to o ls to impro ve me dic a tio n

a dhe re nc e

  • I

de ntify the pha rma c ist’ s/ te c hnic ia n’ s ro le in me dic a tio n a dhe re nc e

Among patie nts with c hr

  • nic illne ss,

appr

  • ximate ly _____ do not take me dic ations

as pr e sc r ibe d. Among patie nts with c hr

  • nic illne ss,

appr

  • ximate ly _____ do not take me dic ations

as pr e sc r ibe d. a . 25% b . 50% c . 75%

  • d. 95%

a . 25% b . 50% c . 75%

  • d. 95%
slide-3
SLIDE 3

6/10/2019 3

Whic h of the following tools ar e use d to impr

  • ve me dic ation adhe r

e nc e ? Whic h of the following tools ar e use d to impr

  • ve me dic ation adhe r

e nc e ?

a . Sma rt Pill Bo ttle s b . I ng e stib le Pill Se nso rs c . Mo b ile Apps

  • d. All o f the a b o ve

a . Sma rt Pill Bo ttle s b . I ng e stib le Pill Se nso rs c . Mo b ile Apps

  • d. All o f the a b o ve

Me dic ation adhe r e nc e is the re sponsibility of _____________. Me dic ation adhe r e nc e is the re sponsibility of _____________.

a . the pa tie nt. b . the pro vide r. c . the pha rma c ist.

  • d. a ll o f the a b o ve .

a . the pa tie nt. b . the pro vide r. c . the pha rma c ist.

  • d. a ll o f the a b o ve .
slide-4
SLIDE 4

6/10/2019 4

“Dr ugs don’t wor k in patie nts who don’t take the m.” “Dr ugs don’t wor k in patie nts who don’t take the m.”

F

  • rme r Surg e o n Ge ne ra l C. E

ve re tt K

  • o p

F

  • rme r Surg e o n Ge ne ra l C. E

ve re tt K

  • o p

Me dic ation Adhe r e nc e Statistic s Me dic ation Adhe r e nc e Statistic s

  • Amo ng pa tie nts with c hro nic illne ss, ~50% do no t

ta ke me dic a tio ns a s pre sc rib e d.

  • Po o r a dhe re nc e is e stima te d to inc ur c o sts o f $100-

$300 b illio n/ ye a r.

  • No na dhe re nc e c a use s 125,000 de a ths a nnua lly
  • Amo ng pa tie nts with c hro nic illne ss, ~50% do no t

ta ke me dic a tio ns a s pre sc rib e d.

  • Po o r a dhe re nc e is e stima te d to inc ur c o sts o f $100-

$300 b illio n/ ye a r.

  • No na dhe re nc e c a use s 125,000 de a ths a nnua lly
slide-5
SLIDE 5

6/10/2019 5

Why is adhe r e nc e a pr

  • ble m?

Why is adhe r e nc e a pr

  • ble m?
  • Uninte ntio na l
  • Uninte ntio na l

Why is adhe r e nc e a pr

  • ble m?

Why is adhe r e nc e a pr

  • ble m?
  • Side e ffe c ts
  • Side e ffe c ts
slide-6
SLIDE 6

6/10/2019 6

Why is adhe r e nc e a pr

  • ble m?

Why is adhe r e nc e a pr

  • ble m?
  • Misunde rsta nding
  • Misunde rsta nding

Me dic ation Adhe r e nc e T

  • ols

Me dic ation Adhe r e nc e T

  • ols
  • I

ng e stib le Pill Se nso rs

  • Sma rt Pill Bo ttle s
  • Adhe re nc e Pa c ka g ing
  • No t ide a l fo r ra pidly c ha ng ing dise a se sta te s
  • Me dic a tio n Co mplia nc e Pro g ra ms
  • I

ng e stib le Pill Se nso rs

  • Sma rt Pill Bo ttle s
  • Adhe re nc e Pa c ka g ing
  • No t ide a l fo r ra pidly c ha ng ing dise a se sta te s
  • Me dic a tio n Co mplia nc e Pro g ra ms
slide-7
SLIDE 7

6/10/2019 7

Me dic ation Adhe r e nc e T

  • ols, c ont.

Me dic ation Adhe r e nc e T

  • ols, c ont.
  • Mo b ile Apps
  • 160 re la te d to me dic a tio n a dhe re nc e
  • Me diSa fe – 81% a dhe re nc e ra te a mo ng use rs
  • Pro s: c he a p, e a sily a c c e ssib le , inc lude me dic a tio n re fe re nc e s
  • Co ns: use r de pe nde nt, indire c t me a sure me nt, se c urity issue s
  • Mo b ile Apps
  • 160 re la te d to me dic a tio n a dhe re nc e
  • Me diSa fe – 81% a dhe re nc e ra te a mo ng use rs
  • Pro s: c he a p, e a sily a c c e ssib le , inc lude me dic a tio n re fe re nc e s
  • Co ns: use r de pe nde nt, indire c t me a sure me nt, se c urity issue s

Me dic ation Adhe r e nc e T

  • ols, c ont.

Me dic ation Adhe r e nc e T

  • ols, c ont.
  • Mo b ile T

e xt Me ssa g ing

  • At le a st 80% o f Ame ric a ns o wn so me type o f c e ll pho ne
  • Me ta -a na lysis o f 16 RCT

s sho we d a n inc re a se o f 17.8% in a dhe re nc e ra te s

  • Mo b ile T

e xt Me ssa g ing

  • At le a st 80% o f Ame ric a ns o wn so me type o f c e ll pho ne
  • Me ta -a na lysis o f 16 RCT

s sho we d a n inc re a se o f 17.8% in a dhe re nc e ra te s

slide-8
SLIDE 8

6/10/2019 8

T he Pharmac ist’s Role T he Pharmac ist’s Role

  • 4,785 a c tive pha rma c ists re g iste re d in Okla ho ma
  • Adhe re nc e ra te s o f 80% o r mo re a re ne e de d fo r
  • ptima l the ra pe utic e ffic a c y
  • Adhe re nc e ra te s inc re a se whe n te c hno lo g y is

c o mb ine d with fa c e -to -fa c e inte rve ntio n

  • Co nside r me dic a tio n no na dhe re nc e first a s the

re a so n a pa tie nt’ s c o nditio n is no t unde r c o ntro l

  • 4,785 a c tive pha rma c ists re g iste re d in Okla ho ma
  • Adhe re nc e ra te s o f 80% o r mo re a re ne e de d fo r
  • ptima l the ra pe utic e ffic a c y
  • Adhe re nc e ra te s inc re a se whe n te c hno lo g y is

c o mb ine d with fa c e -to -fa c e inte rve ntio n

  • Co nside r me dic a tio n no na dhe re nc e first a s the

re a so n a pa tie nt’ s c o nditio n is no t unde r c o ntro l

Among patie nts with c hr

  • nic illne ss,

appr

  • ximate ly _____ do not take me dic ations

as pr e sc r ibe d. Among patie nts with c hr

  • nic illne ss,

appr

  • ximate ly _____ do not take me dic ations

as pr e sc r ibe d. a . 25% b . 50% c . 75%

  • d. 95%

a . 25% b . 50% c . 75%

  • d. 95%
slide-9
SLIDE 9

6/10/2019 9

Whic h of the following tools ar e use d to impr

  • ve me dic ation adhe r

e nc e ? Whic h of the following tools ar e use d to impr

  • ve me dic ation adhe r

e nc e ?

a . Sma rt Pill Bo ttle s b . I ng e stib le Pill Se nso rs c . Mo b ile Apps

  • d. All of the above

a . Sma rt Pill Bo ttle s b . I ng e stib le Pill Se nso rs c . Mo b ile Apps

  • d. All of the above

Me dic ation adhe r e nc e is the re sponsibility of _____________. Me dic ation adhe r e nc e is the re sponsibility of _____________.

a . the pa tie nt. b . the pro vide r. c . the pha rma c ist.

  • d. all of the above .

a . the pa tie nt. b . the pro vide r. c . the pha rma c ist.

  • d. all of the above .
slide-10
SLIDE 10

6/10/2019 10

Re fe r e nc e s Re fe r e nc e s

  • Aung st, T

., (2015). Mo b ile T e c hno lo g y to I mpro ve Me dic a tio n Adhe re nc e . Pharmac y T ime s. Ac c e sse d Ja nua ry 25, 2018. https:/ / www.pha rma c ytime s.c o m/ c o ntrib uto r/ timo thy- a ung st-pha rmd/ 2015/ 04/ mo b ile -te c hno lo g y-to -impro ve -me dic a tio n-a dhe re nc e .

  • Bro wn, M. T

., & Busse ll, J. K . (2011). Me dic a tio n Adhe re nc e : WHO Ca re s? Mayo Clinic Pro c e e dings, 86(4), 304-314. do i:10.4065/ mc p.2010.0575

  • De Be ne de tte , V. (2018). Ge t Sta rte d with Co mplia nc e Pa c ka g ing . Drug T
  • pic s, 162(11), 33.
  • K

im, J., Co mb s, K ., Do wns, J., & T illma n, F . (2018). Me dic a tio n Adhe re nc e : T he E le pha nt in the Ro o m. U S Pharmac ist, 43(1), 30-34.

  • Se de rstro m, J. (2018). He lp Se nio rs Ma na g e T

he ir Me ds. Drug T

  • pic s, 162(11), 20-21.
  • Aung st, T

., (2015). Mo b ile T e c hno lo g y to I mpro ve Me dic a tio n Adhe re nc e . Pharmac y T ime s. Ac c e sse d Ja nua ry 25, 2018. https:/ / www.pha rma c ytime s.c o m/ c o ntrib uto r/ timo thy- a ung st-pha rmd/ 2015/ 04/ mo b ile -te c hno lo g y-to -impro ve -me dic a tio n-a dhe re nc e .

  • Bro wn, M. T

., & Busse ll, J. K . (2011). Me dic a tio n Adhe re nc e : WHO Ca re s? Mayo Clinic Pro c e e dings, 86(4), 304-314. do i:10.4065/ mc p.2010.0575

  • De Be ne de tte , V. (2018). Ge t Sta rte d with Co mplia nc e Pa c ka g ing . Drug T
  • pic s, 162(11), 33.
  • K

im, J., Co mb s, K ., Do wns, J., & T illma n, F . (2018). Me dic a tio n Adhe re nc e : T he E le pha nt in the Ro o m. U S Pharmac ist, 43(1), 30-34.

  • Se de rstro m, J. (2018). He lp Se nio rs Ma na g e T

he ir Me ds. Drug T

  • pic s, 162(11), 20-21.

Using T e c hnology to Impr

  • ve

Me dic ation Adhe r e nc e Using T e c hnology to Impr

  • ve

Me dic ation Adhe r e nc e

L a c e y Bla nke nship, Pha rm.D., BCPS, NCPS Chie f Pha rma c ist, Musc o g e e (Cre e k) Na tio n, Oke ma h I ndia n He a lth Clinic L a c e y Bla nke nship, Pha rm.D., BCPS, NCPS Chie f Pha rma c ist, Musc o g e e (Cre e k) Na tio n, Oke ma h I ndia n He a lth Clinic